Coronavirus vaccine | Pfizer could get United Kingdom approval this week, says Telegraph

Henrietta Brewer
November 23, 2020

Now, the government has noted that the United States is expecting to start COVID-19 vaccinations by December 11, 2020.

Pedestrians pass by the Pfizer world headquarters in NY.

"I'm very, very concerned about the hesitancy as it exists", Slaoui told ABC earlier on Sunday.

Once a vaccine receives emergency use authorization, the Operation Warp Speed program will begin shipping vaccines to distribution centers across the U.S. However, immunization can not start until the CDC's Advisory Committee on Immunization Practices meet and issue a recommendation on who gets the vaccines first.

Many people are trying to get tested before the holiday on Thursday, leading to long lines in New York City and elsewhere. A Gallup poll from Tuesday showed that 58 percent of Americans said they would get a coronavirus vaccine and 42 percent said they wouldn't.


Dr. Anthony Fauci, America's top infectious disease expert, offered a more conservative timeline, telling CNN last week that he thinks the nation could start getting back to relative normality by April or July of 2021 and saying he thought that would be possible to achieve by the second or third quarter next year.

"Most people need to be immunised before we can go back to a normal life", he said.

Slaoui said that while the trials had ensured only short-term safety, decades of experience showed that almost all adverse effects of vaccines occurred within 40 days of being administered, while the current trials protectively covered 60 days.

"You can have a highly efficacious vaccine and only a relatively small 40, 50% of people get vaccinated, you're not going to get the herd immunity you need", Fauci told CBS.

As new COVID-19 cases continue to surge, millions of Americans are ignoring federal and state warnings to stay home for Thanksgiving to prevent overwhelming already strained hospitals.


Slaoui added Sunday that while the vaccine is under consideration for emergency use by the FDA, the US Centers for Disease Control and Prevention and its Advisory Committee on Immunization Practices will look into the data on the vaccines and issue guidance to all the states regarding which populations should be prioritized for the distribution of the vaccine.

Pfizer, which was reported as 95 per cent effective, has said the emergency use of its vaccine could start the process early and the doses could be available as early as next month.

Officials have yet to announce which groups in the population would receive the vaccine first, though health care workers are certain to receive priority, followed by vulnerable groups like the elderly. Two doses are required per person for the Pfizer, Sputnik V and Moderna vaccines.

"Within 24 hours from the approval, the vaccine will be moving and located in the areas where each state will have told us where they want the vaccine doses", Slaoui told NBC's "Meet the Press".


Other reports by iNewsToday

FOLLOW OUR NEWSPAPER